⌕
Establishment Labs Holdings · ESTA · Nasdaq
Tenet 30 · Weak
Compare
$69.51−0.44%At closeTenet 30 · Weak
$69.51−0.31 (−0.44%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Establishment Labs Holdings (ESTA) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~13.6%/yr (FY21→FY25), net margin −24.2%. Worth your attention in FY25: Share count (+23.6%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲27.1%
211.1
FY21→FY25CAGR +13.6%/yr
Net income ($M)▲39.6%
−51.1
one-off year: see footnoteCAGR —
Free cash flow ($M)▲15.1%
−56.9
FY21→FY25CAGR —
Diluted EPS▲42.7%
−1.72
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+23.6%

24.0mn → 29.6mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$6.0M

−29.1% YoY in FY25 · 2.9% of revenue.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)211.1Revenue−64.8COGS146.3Gross profit−20.2R&D−165.1SG&A−39.0Op income−12.1Tax & other−51.1Net income

-24¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
705335180%sector median net margin ~3%FY21FY25

Over this window: gross 67.4% → 69.3%. Net margin -24.2% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
264,029.0211,076.0166,025.0165,151.0161,700.0126,682.0▲27.1%+13.6%
Cost of revenue
78,737.064,768.056,500.058,174.055,105.041,278.0▲14.6%+11.9%
Gross profit
185,292.0146,308.0109,525.0106,977.0106,595.085,404.0▲33.6%+14.4%
Research & development
20,084.020,247.019,706.026,428.020,269.018,315.0▲2.7%+2.5%
Selling, general & admin
182,561.0165,069.0139,806.0145,575.0125,984.092,229.0▲18.1%+15.7%
Total operating expenses
202,645.0185,316.0159,512.0172,003.0146,253.0110,544.0▲16.2%+13.8%
Operating incomefeeds ROC rank
−17,353.0−39,008.0−49,987.0−65,026.0−39,658.0−25,140.0▲22.0%—
Other income, net
−29,495.0−19,014.0−34,641.0−13,557.0−33,166.0−14,572.0——
Pretax income
−46,848.0−58,022.0−84,628.0−78,583.0−72,824.0−39,712.0▲31.4%—
Income tax
−8,394.0−6,958.0−32.0−81.02,385.01,427.0▼21643.8%—
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−38,454.0−51,064.0−84,596.0−78,502.0−75,209.0−41,139.0▲39.6%—
Per share
Diluted EPSbuyback-sensitive
−1.26−1.72−3.00−3.07−3.08−1.72▲42.7%—
Diluted shares (mn)
30.4329.6228.1625.6024.4623.97▲5.2%+5.4%
Margins
Gross margin58th pct in Healthcare
70.2%69.3%66.0%64.8%65.9%67.4%▲3.3pp+1.9pp
Operating margin
−6.6%−18.5%−30.1%−39.4%−24.5%−19.8%▲11.6pp+1.4pp
Net margin25th pct in Healthcare
−14.6%−24.2%−51.0%−47.5%−46.5%−32.5%▲26.8pp+8.3pp
† TTM = trailing four quarters through 2026-09-30.FY25 effective tax rate was 12% vs a 0% norm for this window, likely a one-time item; see the filing.
FY17 – FY20 · 4 more years
Unlock the full history →
4 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-27 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Establishment Labs Holdings' revenue last fiscal year?

Establishment Labs Holdings reported revenue of $211.1M in fiscal 2025, up 27.1% from fiscal 2024.

What was Establishment Labs Holdings' net income?

Establishment Labs Holdings reported net income of −$51.1M in fiscal 2025, a net margin of −24.2%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.